BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
David Brühlmann is leading a team of scientists at Merck’s Biologics Technology Innovation having the mission to develop novel and innovative cell-culture technologies including cell line development, media design, high-throughput cell culture technologies and online process monitoring. In his preceding role at Merck, he oversaw international large-scale manufacturing technology transfers of clinical and marketed products. He holds a PhD in biology in the field of glycosylation of the University of Würzburg, Germany and a master’s degree in chemical engineering from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland.